Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Oliveira, Patrícia Mouta Nunes de | - |
Autor(es): dc.creator | Buonora, Sibelle Nogueira | - |
Autor(es): dc.creator | Souza, Cristina Letícia Passos | - |
Autor(es): dc.creator | Simões Júnior, Robinson | - |
Autor(es): dc.creator | Silva, Thais Carolina da | - |
Autor(es): dc.creator | Bom, Gabriel José Teixeira | - |
Autor(es): dc.creator | Teixeira, Caio Henrique da Silva | - |
Autor(es): dc.creator | Silva, André Ricardo Araujo da | - |
Data de aceite: dc.date.accessioned | 2024-07-11T17:38:51Z | - |
Data de disponibilização: dc.date.available | 2024-07-11T17:38:51Z | - |
Data de envio: dc.date.issued | 2023-05-23 | - |
Data de envio: dc.date.issued | 2023-05-23 | - |
Data de envio: dc.date.issued | 2019 | - |
Fonte completa do material: dc.identifier | http://app.uff.br/riuff/handle/1/28968 | - |
Fonte completa do material: dc.identifier | https://10.1590/0037-8682-0205-2019 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/754568 | - |
Descrição: dc.description | Introduction: Multi-drug-resistant bacteria surveillance (MDR) systems are used to identify the epidemiology of MDR bacteria in neonates and children. This study aimed to describe the patterns by which MDR bacteria colonize and infect neonatal (NICU) and pediatric intensive care unit (PICU) patients in the state of Rio de Janeiro State, Brazil. Methods: A cross-sectional survey was performed using electronic data on NICU and PICU patients reported to the Rio de Janeiro State MDR bacteria surveillance system. All healthcare institutions that reported at least one case during the study period were included. Results: Between 2014 and 2017, 10,210 MDR bacteria cases, including 9261 colonizations and 949 infections, were reported. Among the colonizations, 5379 occurred in NICUs and 3882 in PICUs, while 405 infections occurred in NICUs and 544 in PICUs. ESBL producing Klebsiella sp and E. coli were the most reported colonization-causing agents in NICUs (1983/5379, 36.9%) and PICUs (1494/3882; 38.5%). The main causing bacteria reported in catheter-associated bloodstream infection (CLABSI), ventilator associated pneumonia, and catheter-associated urinary tract infection in NICUs were Klebsiella sp and E.coli (56/156, 35.9%), carbapenem-resistant Gram-negative bacteria (CRGNB) (22/65, 33.9%), and CRGNB (11/36, 30.6%) respectively, while in PICUs, they were MRSA (53/169, 31.4%), CRGNB (50/87, 57.4%), Klebsiella sp and E.coli (18/52, 34.6%), respectively. Conclusions: MDR Gram-negative bacteria (ESBL producers and carbapenem-resistant bacteria) were the most reported agents among MDR bacteria reported to Rio de Janeiro surveillance system. Except for CLABSI in children, they caused all deviceassociated infections in NICUs and PICUs. | - |
Descrição: dc.description | Sim | - |
Descrição: dc.description | Introduction: Multi-drug-resistant bacteria surveillance (MDR) systems are used to identify the epidemiology of MDR bacteria in neonates and children. This study aimed to describe the patterns by which MDR bacteria colonize and infect neonatal (NICU) and pediatric intensive care unit (PICU) patients in the state of Rio de Janeiro State, Brazil. Methods: A cross-sectional survey was performed using electronic data on NICU and PICU patients reported to the Rio de Janeiro State MDR bacteria surveillance system. All healthcare institutions that reported at least one case during the study period were included. Results: Between 2014 and 2017, 10,210 MDR bacteria cases, including 9261 colonizations and 949 infections, were reported. Among the colonizations, 5379 occurred in NICUs and 3882 in PICUs, while 405 infections occurred in NICUs and 544 in PICUs. ESBL producing Klebsiella sp and E. coli were the most reported colonization-causing agents in NICUs (1983/5379, 36.9%) and PICUs (1494/3882; 38.5%). The main causing bacteria reported in catheter-associated bloodstream infection (CLABSI), ventilator associated pneumonia, and catheter-associated urinary tract infection in NICUs were Klebsiella sp and E.coli (56/156, 35.9%), carbapenem-resistant Gram-negative bacteria (CRGNB) (22/65, 33.9%), and CRGNB (11/36, 30.6%) respectively, while in PICUs, they were MRSA (53/169, 31.4%), CRGNB (50/87, 57.4%), Klebsiella sp and E.coli (18/52, 34.6%), respectively. Conclusions: MDR Gram-negative bacteria (ESBL producers and carbapenem-resistant bacteria) were the most reported agents among MDR bacteria reported to Rio de Janeiro surveillance system. Except for CLABSI in children, they caused all deviceassociated infections in NICUs and PICUs. | - |
Formato: dc.format | application/pdf | - |
Idioma: dc.language | en | - |
Publicador: dc.publisher | SBMT | - |
Publicador: dc.publisher | Niterói, RJ | - |
Relação: dc.relation | JOURNAL OF THE BRAZILIAN SOCIETY OF TROPICAL MEDICINE/REVISTA BRASILEIRA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL. Uberaba: SBMT, 1967-2023. Bimestral. ISSN: 1678-9849 | - |
Direitos: dc.rights | Open Access | - |
Direitos: dc.rights | CC-BY-SA | - |
Palavras-chave: dc.subject | Surveillance | - |
Palavras-chave: dc.subject | Neonates | - |
Palavras-chave: dc.subject | Children | - |
Palavras-chave: dc.subject | Healthcare-associated infection | - |
Palavras-chave: dc.subject | Multidrug resistant bacteria | - |
Palavras-chave: dc.subject | Neonato | - |
Palavras-chave: dc.subject | Criança | - |
Palavras-chave: dc.subject | Bactéria | - |
Palavras-chave: dc.subject | Unidade de terapia intensiva | - |
Título: dc.title | Surveillance of multidrug-resistant bacteria in pediatric and neonatal intensive care units in Rio de Janeiro State, Brazil | - |
Título: dc.title | Surveillance of multidrug-resistant bacteria in pediatric and neonatal intensive care units in Rio de Janeiro State, Brazil | - |
Tipo de arquivo: dc.type | Artigo de periódicos | - |
Aparece nas coleções: | Repositório Institucional da Universidade Federal Fluminense - RiUFF |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: